Vincerx Pharma Inc. (VINC)
NASDAQ: VINC
· Real-Time Price · USD
0.05
-0.00 (-1.96%)
At close: Jun 09, 2025, 12:40 PM
Vincerx Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5M | -7.99M | -7.84M | -1.81M | -12.43M | -4.95M | -9.71M | -11.15M | -14.34M | -13.64M | -16.88M | -18.42M | -16.42M | -6.47M | -24.52M | -2.03M | -6.28M |
Depreciation & Amortization | n/a | 281K | 275K | 270K | 264K | 258K | 254K | 249K | 154K | 241K | 236K | 232K | 230K | 343K | 48K | -26K | -25K |
Stock-Based Compensation | 435K | 610K | 1.42M | 912K | 528K | 457K | 1.34M | 385K | 1.38M | 1.53M | 2.29M | 3.36M | 5.26M | 5.89M | 6.08M | 6.64M | 4.71M |
Other Working Capital | n/a | 1.39M | -878K | 903K | -992K | -3.26M | 2.15M | 206K | -2.11M | -412K | 184K | -1.59M | -248K | 234K | 1.08M | 1.24M | 1.53M |
Other Non-Cash Items | n/a | -532K | 217K | -5.33M | 6.57M | 1.56M | -205K | 10.46M | -355K | -204K | 22K | -1.2M | -5.21M | -11.26M | 6.61M | -15.36M | -3.35M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -1.53M | n/a | -10.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | 1.45M | -451K | 125K | -1.31M | -3.82M | 1.68M | -2.43M | 375K | -1.74M | -541K | 142K | 1.12M | 13K | 1.49M | 2.61M | 1.5M |
Operating Cash Flow | -4.45M | -6.18M | -6.38M | -5.83M | -7.74M | -8.02M | -6.64M | -12.7M | -13.09M | -13.82M | -14.87M | -15.89M | -15.03M | -11.49M | -10.3M | -8.18M | -3.44M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8K | -22K | -228K | -5M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | -5M |
Purchase of Investments | n/a | n/a | -3.13M | -8.34M | n/a | n/a | -1.23M | -6.4M | -4.19M | -22.78M | -20.2M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | 7.17M | 4.5M | n/a | n/a | 5.75M | 16.29M | 21.2M | 10.08M | 2.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | 5.75K | 15.06K | 14.8K | 5.88K | -20.38K | -20.2K | n/a | n/a | -8K | n/a | -5M | -5M |
Investing Cash Flow | n/a | 7.17M | 1.37M | -8.34M | n/a | 5.75M | 15.06M | 14.8M | 5.88M | -20.38M | -20.2M | n/a | n/a | -8K | -22K | -228K | -5M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.86M | 24K | -94K | 17M | 5K | 18K | n/a | 93K | 3K | 38K | n/a | 242K | n/a | 283K | 47.5M | 40.67M | n/a |
Financial Cash Flow | 3.86M | 985K | n/a | 17M | 5K | 18K | n/a | 93K | 3K | 38K | n/a | 242K | n/a | 283K | 47.5M | 40.67M | n/a |
Net Cash Flow | -547K | 2.04M | -4.98M | 2.81M | -7.66M | -2.29M | 8.4M | 2.19M | -7.17M | -34.13M | -35.05M | -15.63M | -15.01M | -11.23M | 37.17M | 32.27M | -8.44M |
Free Cash Flow | -4.45M | -6.18M | -6.38M | -5.83M | -7.74M | -8.02M | -6.64M | -12.7M | -13.09M | -13.82M | -14.87M | -15.89M | -15.03M | -11.49M | -10.33M | -8.4M | -8.44M |